ASCIA Guidelines – Standardised infusion rates for intravenous immunoglobulin replacement therapy

These Guidelines are currently under review and have therefore been removed from the ASCIA website in May 2024.

In the meantime, we suggest that clinicians follow the information from the suppliers of each IVIg product.

For paediatric patients on IVIg the RCH VIC IVIg Guidelines may be useful: